Welcome - Register - Login - Help/FAQ - 0 items

Search Enter keywords, a title or a report id number below. In All Categories --------------------- Telecom & Computing Business & Finance Mfg & Construction Pharma & Healthcare Consumer & Retail Gov & Public Sector Energy & Transport Country Reports Company Reports --------------------- Transcripts Advanced      Select a currency for use throughout the site Australia Dollars Canada Dollars Euro Japan Yen Sweden Kroner Switzerland Francs UK Pounds US Dollars Search Results Your Search for 'Urinary Incontinence: Major Milestones' returned 17 results - Page 1 of 1   Sort by    Date Published ASC Date Published DESC Report Price ASC Report Price DESC Rank ASC Rank DESC   Sorted by Rank Top-Bottom Urinary Incontinence Therapy Area Pipeline Report   Life Science Analytics, March 2011, Pages: 131 Incontinence Products --Top 5 Companies in Marketed Urinary Incontinence Products Patent Expirations Upcoming Milestones Product Sales Full Pipeline View --Product Details : Unknown/Research --Product Details Urinary Incontinence (UI) Therapeutics - Pipeline Assessment and Market Forecasts to 2018   GlobalData, Nov 2011, Pages: 85 Urinary Incontinence (UI) Therapeutics - Pipeline Assessment and Market Forecasts to 2018 Summary GlobalData, the industry analysis specialist, has released its new report, “Urinary Incontinence GT Urological, LLC - Product Pipeline Analysis   GlobalData, Oct 2011, Pages: 15 products for the urinary incontinence market. The company is involved in developing surgically implantable devices to restore urinary control to both male and female sufferers of long-term stress urinary American Medical Systems Holdings, Inc. - Product Pipeline Analysis   GlobalData, Sep 2011, Pages: 33 Description AdVance XP Male Sling System - Product Milestone AdVance XP Male Sling System - A Post-Market Study of the AMS AdVance Male Sling System for the Treatment of Male Stress Urinary Incontinence Vysera Biomedical Limited - Product Pipeline Analysis   GlobalData, March 2011, Pages: 14 For Crohn's Disease 9 Product Status 9 Product Description 9 GERD Device 9 Product Status 9 Product Description 9 Urinary Incontinence Device 10 Product Status 10 Product Description 10 Vysera Tengion, Inc. (TNGN) - Product Pipeline Analysis   GlobalData, Aug 2011, Pages: 30 by Milestone Summary Neo Bladder Augment Urge Incontinence Product Status Product Description Neo Bladder Conduit Product Status Product Description Neo Kidney Augment - Chronic Anemia Product Plethora Solutions Holdings plc - Product Pipeline Review - Q4 2010   GlobalData, Nov 2010, Pages: 34 and clinical stage products of Plethora Solutions Holdings plc with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones. - Recent Plethora Solutions Holdings plc - Product Pipeline Review - Q4 2010   Global Markets Direct, Nov 2010, Pages: 34 and clinical stage products of Plethora Solutions Holdings plc with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones. - Recent Kyowa Hakko Kirin Pharma, Inc. - Product Pipeline Review - Q4 2010   GlobalData, Nov 2010, Pages: 39 and clinical stage products of Kyowa Hakko Kirin Pharma, Inc. with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones. - Recent Kyowa Hakko Kirin Pharma, Inc. - Product Pipeline Review - Q4 2010   Global Markets Direct, Nov 2010, Pages: 39 and clinical stage products of Kyowa Hakko Kirin Pharma, Inc. with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones. - Recent FemmePharma Global Healthcare, Inc. - Product Pipeline Review - Q4 2010   Global Markets Direct, Dec 2010, Pages: 23 Pharma Receives U.S. Ind Approval for its New Therapeutic Option for Female Urinary Incontinence Financial Deals Landscape FemmePharma Global Healthcare, Inc., Deals Summary, 2004 to 2010 Femme North America Nephrology and Urology Devices Investment Opportunities, Analysis and Forecasts to 2012   Global Markets Direct, Jan 2009, Pages: 133 for incontinence 15 3.2.2 Urine Bags 15 3.2.3 Urinary Catheters 15 3.3 Renal Dialysis Equipment 15 3.3.1 Hemodialysis Machines 15 3.3.2 Peritoneal Dialysis Solutions 15 3.3.3 Continuous Renal Replacement Therapy Kissei Pharmaceutical Co., Ltd. - Product Pipeline Review - Q4 2010   GlobalData, Nov 2010, Pages: 51 and clinical stage products of Kissei Pharmaceutical Co., Ltd. with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones. - Recent Kissei Pharmaceutical Co., Ltd. - Product Pipeline Review - Q4 2010   Global Markets Direct, Nov 2010, Pages: 51 and clinical stage products of Kissei Pharmaceutical Co., Ltd. with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones. - Recent Beech Tree Labs, Inc. - Product Pipeline Review - H2 2011   Global Markets Direct, Sep 2011, Pages: 23 for late stage and clinical stage products of Beech Tree Labs, Inc. with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones Allergan, Inc. - Product Pipeline Review - H2 2011   Global Markets Direct, Nov 2011, Pages: 239 description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones. - Recent updates of the Allergan, Inc.’s pipeline in the last quarter. - Key MediciNova, Inc. - Product Pipeline Review - H2 2011   Global Markets Direct, Nov 2011, Pages: 103 stage products of MediciNova, Inc. with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones. - Recent updates of the Medici Results:  First -   Prev -   1 -   Next -   Last

		For enquiries please call us on:   +353-1-415-1241 (GMT Office Hours)   1-800-526-8630 (US/Canada Toll Free)   1-917-300-0470 (EST Office Hours)

All rights reserved. © Copyright 2012 Research and Markets3    Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network